Instrument-Defined Estimates of the Minimally Important Difference for EQ-5D-5L Index Scores

被引:192
|
作者
McClure, Nathan S. [1 ]
Al Sayah, Fatima [1 ]
Xie, Feng [2 ,3 ]
Luo, Nan [4 ]
Johnson, Jeffrey A. [1 ]
机构
[1] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada
[2] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada
[3] St Josephs Healthcare, Program Hlth Econ & Outcome Measures PHENOM, Father Sean OSullivan Res Ctr, Hamilton, ON, Canada
[4] Natl Univ Singapore, Swee Hock Sch Publ Hlth, Singapore, Singapore
关键词
EQ-5D-5L; health state preference; health state utility; minimally important difference; QUALITY-OF-LIFE; RESPONSIVENESS;
D O I
10.1016/j.jval.2016.11.015
中图分类号
F [经济];
学科分类号
02 ;
摘要
Background: The five-level EuroQol five-dimensional questionnaire (EQ-5D-5L) is a preference-based measure of health-related quality of life (HRQOL), which yields an index score anchored at 0 (dead) and 1 (full health). We lack evidence on estimates for the minimally important difference (MID) of the EQ-5D-5L that will help in interpreting differences or changes in HRQOL measured by this scale score. Objectives: To estimate the MID of the EQ-5D-5L index score for available scoring algorithms including algorithms from Canada, China, Spain, Japan, England, and Uruguay. Methods: A simulation based approach based on instrument-defined single-level transitions was used to estimate the MID values of the EQ-5D-5L for each country-specific scoring algorithm. Results: The simulation-based instrument-defined MID estimates (mean +/- SD) for each country specific scoring algorithm were as follows: Canada, 0.056 +/- 0.011; China, 0.069 +/- 0.007; Spain, 0.061 +/- 0.008; Japan, 0.048 +/- 0.004; England, 0.063 +/- 0.013; and Uruguay, 0.063 +/- 0.019. Differences in MID estimates reflect differences in population preferences, in valuation techniques used, as well as in modeling strategies. After excluding the maximum-valued scoring parameters, the MID estimates (mean +/- SD) were as follows: Canada, 0.037 +/- 0.001; China, 0.058 +/- 0.005; Spain, 0.045 +/- 0.009; Japan, 0.044 +/- 0.004; England, 0.037 +/- 0.008; and Uruguay, 0.040 +/- 0.010. Conclusions: Simulation-based estimates of the MID of the EQ-5D-5L index score were generally between 0.037 and 0.069, which are similar to the MID estimates of other preference-based HRQOL measures. Copyright (C) 2017, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.
引用
收藏
页码:644 / 650
页数:7
相关论文
共 50 条
  • [21] A Comparison of the EQ-5D-3L and EQ-5D-5L
    Alexander James Thompson
    Alex James Turner
    PharmacoEconomics, 2020, 38 : 575 - 591
  • [22] ASSESSMENT AND COMPARISON OF EQ-5D-3L, EQ-5D-5L AND ICECAP-A INDEX SCORES IN THE GENERAL AND SPECIFIC GROUPS OF CHINESE POPULATION
    Wu, H.
    Ran, X.
    Cai, Y.
    Zhang, T.
    Xiao, Y.
    Xu, C.
    Xiong, Y.
    Tang, C.
    VALUE IN HEALTH, 2018, 21 : S88 - S88
  • [23] THE EQ-5D-5L INSTRUMENT DEMONTRATES BETTER PERFORMANCE COMPARED WITH THE EQ-5D-3L IN PSORIATIC PATIENTS
    Yfantopoulos, I
    Chantzaras, A.
    Kontodimas, S.
    VALUE IN HEALTH, 2016, 19 (07) : A617 - A617
  • [24] Comparing EQ-5D-3L and EQ-5D-5L performance in common cancers: suggestions for instrument choosing
    Zhu, Juan
    Yan, Xin-Xin
    Liu, Cheng-Cheng
    Wang, Hong
    Wang, Le
    Cao, Su-Mei
    Liao, Xian-Zhen
    Xi, Yun-Feng
    Ji, Yong
    Lei, Lin
    Xiao, Hai-Fan
    Guan, Hai-Jing
    Wei, Wen-Qiang
    Dai, Min
    Chen, Wanqing
    Shi, Ju-Fang
    QUALITY OF LIFE RESEARCH, 2021, 30 (03) : 841 - 854
  • [25] EQ-5D-5L and SF-6D health utility index scores in patients with myasthenia gravis
    Barnett, C.
    Bril, V.
    Bayoumi, A. M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 (03) : 452 - 459
  • [26] A scoping review of the use of minimally important difference of EQ-5D utility index and EQ-VAS scores in health technology assessment
    Shaw, Caroline
    Longworth, Louise
    Bennett, Bryan
    McEntee-Richardson, Louise
    Shaw, James W.
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2024, 22 (01)
  • [27] Comparing EQ-5D-3L and EQ-5D-5L performance in common cancers: suggestions for instrument choosing
    Juan Zhu
    Xin-Xin Yan
    Cheng-Cheng Liu
    Hong Wang
    Le Wang
    Su-Mei Cao
    Xian-Zhen Liao
    Yun-Feng Xi
    Yong Ji
    Lin Lei
    Hai-Fan Xiao
    Hai-Jing Guan
    Wen-Qiang Wei
    Min Dai
    Wanqing Chen
    Ju-Fang Shi
    Quality of Life Research, 2021, 30 : 841 - 854
  • [28] Responsiveness and minimal clinically important difference of the EQ-5D-5L in cervical intraepithelial neoplasia: a longitudinal study
    Xin Hu
    Mingxia Jing
    Mei Zhang
    Ping Yang
    Xiaolong Yan
    Health and Quality of Life Outcomes, 18
  • [29] Validity, responsiveness, and minimal clinically important difference of EQ-5D-5L in stroke patients undergoing rehabilitation
    Poyu Chen
    Keh-Chung Lin
    Rong-Jiuan Liing
    Ching-Yi Wu
    Chia-Ling Chen
    Ku-Chou Chang
    Quality of Life Research, 2016, 25 : 1585 - 1596
  • [30] Responsiveness and minimal clinically important difference of the EQ-5D-5L in cervical intraepithelial neoplasia: a longitudinal study
    Hu, Xin
    Jing, Mingxia
    Zhang, Mei
    Yang, Ping
    Yan, Xiaolong
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2020, 18 (01)